Due to a lack of potential candidate biomarkers for HNSCC patients analogous to the ER or HER2 markers in breast cancers, or c-KIT in gastrointestinal cancers, genomic profiling studies may be useful for identifying new biomarkers with prognostic or predictive value. Here, ESR1 is linked to breast carcinoma.